
Oncolys BioPharma Hits Day High with Strong 7.06% Intraday Surge
2025-11-07 17:03:33Oncolys BioPharma, Inc. has seen a notable rise in stock performance, contrasting with a decline in the Japan Nikkei 225 index. Over the past week and month, the stock has shown significant gains, although long-term challenges persist, including a decline in five-year performance and negative financial metrics.
Read More
Oncolys BioPharma Hits Day High with 7.94% Surge in Stock Price
2025-11-03 18:10:46Oncolys BioPharma, Inc. has seen a notable increase in stock performance today, reaching an intraday high. While the company has achieved a significant year-to-date gain, its long-term performance reveals substantial declines. Additionally, it faces challenges such as negative return on equity and low operating profit growth.
Read More
Oncolys BioPharma Hits Day Low of JPY 774 Amid Price Pressure
2025-10-15 18:22:44Oncolys BioPharma, Inc. saw its stock price decline significantly today, reaching an intraday low amid a challenging trading environment. Despite a strong annual performance, the company's financial metrics reveal issues with management efficiency and negative earnings, raising concerns about its short-term stability in the biotechnology sector.
Read More





